Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
697,567
Value
$33.4M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of NVO by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026697,567$33.4M<0.1%−1,341,539−65.8%ReducedHolders
Q1 20262,039,106$74.9M0.1%+1,193,882+141.3%AddedHolders
Q4 2025845,224$43.0M<0.1%−204,295−19.5%ReducedHolders
Q3 20251,049,519$58.2M<0.1%+1,049,519NewHolders
Q2 20250$00.0%−2,582,572−100.0%Sold outHolders
Q1 20252,582,572$179.3M0.2%+527,584+25.7%AddedHolders
Q4 20242,054,988$176.8M0.2%+1,149,403+126.9%AddedHolders
Q3 2024905,585$107.8M0.1%+858,885+1,839.2%AddedHolders
Q2 202446,700$6.67M<0.1%−89,973−65.8%ReducedHolders
Q1 2024136,673$17.5M<0.1%+97,376+247.8%AddedHolders
Q4 202339,297$4.07M<0.1%−7,033−15.2%ReducedHolders
Q3 202346,330$4.21M<0.1%−182,860−79.8%ReducedConverted for a 2-for-1 splitHolders
Q2 2023114,595$18.5M<0.1%+101,823+797.2%AddedHolders
Q1 202312,772$2.03M<0.1%−497,526−97.5%ReducedHolders
Q4 2022510,298$69.1M0.1%+500,902+5,331.0%AddedHolders
Q3 20229,396$936.0K<0.1%−224,572−96.0%ReducedHolders
Q2 2022233,968$26.1M<0.1%+231,146+8,190.9%AddedHolders
Q1 20222,822$313.0K<0.1%+2,822NewHolders
Q4 20210$00.0%−110,839−100.0%Sold outHolders
Q3 2021110,839$10.6M<0.1%−27,860−20.1%ReducedHolders
Q2 2021138,699$11.6M<0.1%+103,432+293.3%AddedHolders
Q1 202135,267$2.38M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.